4.6 Review

Association of Breast Cancer Irradiation With Cardiac Toxic Effects A Narrative Review

Journal

JAMA ONCOLOGY
Volume 7, Issue 6, Pages 924-932

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2020.7468

Keywords

-

Categories

Ask authors/readers for more resources

It is crucial to promptly recognize and manage cardiovascular risk factors before, during, and after cancer treatment to decrease the risk of cancer therapy-related cardiac dysfunction. Tumors in the left breast, presence of classic cardiovascular risk factors, and adjunctive anthracycline-based chemotherapy may increase the risk of heart disease. Additional research is needed to confirm the feasibility of pharmacological cardioprevention strategies in routine practice.
IMPORTANCE To promptly recognize and manage cardiovascular (CV) risk factors before, during, and after cancer treatment, decreasing the risk of cancer therapy-related cardiac dysfunction is crucial. After recent advances in breast cancer treatment, mortality rates from cancer have decreased, and the prevalence of survivors with a potentially higher CV disease risk has increased. Cardiovascular risks might be associated with the multimodal approach, including systemic therapies and breast radiotherapy (RT). OBSERVATIONS The heart disease risk seems to be higher in patients with tumors in the left breast, when other classic CV risk factors are present, and when adjunctive anthracycline-based chemotherapy is administered, suggesting a synergistic association. Respiratory control as well as modern RT techniques and their possible further refinement may decrease the prevalence and severity of radiation-induced heart disease. Several pharmacological cardioprevention strategies for decreasing cardiac toxic effects have been identified in several guidelines. However, further research is needed to ascertain the feasibility of these strategies in routine practice. CONCLUSIONS AND RELEVANCE This review found that evidence-based recommendations are lacking on the modalities for and intensity of heart disease screening, surveillance of patients after RT, and treatment of these patients. A multidisciplinary and multimodal approach is crucial to guide optimal management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available